Director, Medical Affairs, Oncology, Strategic Evidence & Collaborations

This is a fully remote position, open to applicants in United States.

📋 Description

• Co-create US Medical Affairs congress strategies in collaboration with the Congress Center of Excellence, USMA Strategy, and Field Based Medical Teams.

• Advocate for and take into account the US healthcare landscape with both internal and external stakeholders regarding approved and upcoming oncology treatments.

• Develop and implement a comprehensive US evidence-generation strategy across various cancer types.

• Partner with cooperative groups, NCI/CTEP, and other significant organizations.

• Contribute to the formulation of US and Global Medical Affairs Strategic Plans, Integrated Strategic Plans, and Action Plans.

• Create strategies and execution plans that address educational needs, research, medical affairs insights, and data generation requirements.

• Prepare presentation materials and deliver scientific data at internal meetings and external advisory boards.

• Assist in global and regional congress strategic planning and tactical execution.

• Lead or assist in the medical initiatives and strategic planning of US oncology societies.

• Provide medical and scientific guidance at scientific gatherings with US healthcare professionals and patients.

• Act as a resource for Gilead team members, including US Medical Science Liaisons.

• Facilitate medical educational efforts, grants, and investigator-sponsored/collaborative studies.

• Work with Medical Affairs Research and Clinical R&D on collaborative research efforts.

• Deliver balanced clinical and scientific presentations to healthcare professionals as needed.

• Engage in the editorial review of scientific content to ensure strategic alignment and accuracy.

• Support disease-specific publication strategies and data generation initiatives.

• Evaluate collaboration research, Phase 3b, and Phase 4 study proposals, abstracts, and manuscripts.

• Communicate Gilead’s dedication to scientific excellence through research and education.

• Collaborate in compliance with colleagues throughout Gilead.

• Undertake additional activities that support the development and tactical execution of US Medical Affairs strategies.

⛳️ Requirements

• Advanced medical/scientific degree (Ph.D., MD, or PharmD) with 8+ years of Medical Affairs experience or equivalent industry experience; OR MA/MS with 10+ years; OR BA/BS with 12+ years.

• Minimum of 8 years (96 months) of experience required under the advanced-degree pathway.

• Preferred experience of 10+ years in Medical Affairs or a related field.

• Oncology experience is preferred.

• Ability to think strategically and translate strategies into actionable work plans.

• Exceptional written, verbal, interpersonal, relationship-building, negotiation, and communication skills.

• Strong organizational, teamwork, analytical, problem-solving, and project planning abilities.

• Capability to identify complex issues and extract key findings from study data and publications.

• Experience in developing abstracts, manuscripts, posters, and slides, as well as presenting at scientific meetings.

• In-depth knowledge of FDA regulations, ICH guidelines, and GCPs related to clinical trials is preferred.

• Ability to work autonomously and independently.

• Ability to comply with regulatory and legal Business Conduct requirements for clinical trials and Medical Affairs activities.

• Willingness to travel over 50% of the time, including both domestic and international travel.

• Proven alignment with Gilead Core Values: Integrity, Teamwork, Excellence, Accountability, and Inclusion.

🏝️ Benefits

• Discretionary annual bonus.

• Discretionary stock-based long-term incentives.

• Paid time off.

• Company-sponsored medical insurance.

• Company-sponsored dental insurance.

• Company-sponsored vision insurance.

• Company-sponsored life insurance.

• Equal employment opportunity and an inclusive work environment.

• Reasonable accommodation support during the application process.